Honesty About Cancer Drug Doubts Shifts Patient Choices

New cancer drugs often get approved even when experts are not fully sure about the good or the bad parts. Usually, patients do not hear about these doubts. A pair of studies wanted to change that. They asked a simple question. Does telling people the honest truth about the shaky evidence change how they decide to take the medicine?

To find out, researchers ran two separate tests using regular adults online. They made sure the group matched the country well, balancing age, sex, income, education, and race and ethnicity. This work took place from May 9 through July 26 in 2025. Rather than using hard medical words, the team wrote plain sentences explaining the uncertainty.

In the first test, volunteers were split into five groups. Each group learned about one specific worry. Maybe the study only tracked one group of patients. Maybe the people tested did not match the country's mix. Maybe the time was too short or the results relied on a stand-in measure. Some were told it was unclear if patients would notice any real change.

The second test combined one, two, three, or four of these worries. They compared those groups against a control group that received no extra details. They also tracked how worried people felt, how effective the drug seemed, and how much they trusted the information and the FDA.

A total of 6272 adults joined the main analysis. About 49.5% of them were women. When participants learned about the uncertainties, their willingness to take the drug went down. On average, the decision rate dropped by 10.1 percentage points. This happened for every type of uncertainty shared. The drop was largest when people heard it was unknown if the drug actually helped, falling by 14.1 percentage points.